Skip to main content
. 2020 Sep 4;15(9):e0238406. doi: 10.1371/journal.pone.0238406

Fig 4. The 20S proteasome chymotrypsin-like (ChT-L) activity, IL-8, CCL2, NF-κB1 and NF-κB2 concentrations in brain tumor patients who died compared to brain tumor patients who survived the following two years.

Fig 4